SOUTH BEND, IN—a large and growing patient population is creating enormous costs to care for heart failure patients. Warning signs often develop gradually before rehospitalization is required, but only expensive and invasive measurements have proven effective at catching signs early enough to intervene. As a result, readmissions and costs remain high.

Vital View’s non-contact fluid balance monitoring system provides actionable data clinicians can use to take steps to prevent costly readmissions.  Further, the patient experience is convenient and non-contact.  A University of Notre Dame IDEA Center venture, Vital View’s potential impact on patient outcomes and Indiana’s economy is tremendous.

$100B

projected cost of heart failure patient care in 2030

8M

projected patient population by 2030

1M

hospitalizations annually

Vital View’s proprietary and protected technology offers it unparalleled resolution capabilities.

2022 Impact Priorities

 Product development

 Raise additional investment capital

Learn More

Connect with Commonwealth and learn how the places and causes
you care about can be transformed with impact investing.

Disclaimer: This page is for informational purposes only. You should not construe any information or other material as legal, tax, investment, financial, or other advice. Nothing contained in these materials constitutes a solicitation, recommendation, endorsement, or offer.